Literature DB >> 466137

Treatment of angioedema.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 466137      PMCID: PMC1599186     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  9 in total

1.  A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.

Authors:  V H DONALDSON; R R EVANS
Journal:  Am J Med       Date:  1963-07       Impact factor: 4.965

2.  HEREDITARY ANGIONEUROTIC EDEMA: TWO GENETIC VARIANTS.

Authors:  F S ROSEN; J PENSKY; V DONALDSON; P CHARACHE
Journal:  Science       Date:  1965-05-14       Impact factor: 47.728

3.  Tranexamic acid therapy in hereditary angioneurotic edema.

Authors:  A L Sheffer; K F Austen; F S Rosen
Journal:  N Engl J Med       Date:  1972-08-31       Impact factor: 91.245

4.  Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study.

Authors:  M M Frank; J S Sergent; M A Kane; D W Alling
Journal:  N Engl J Med       Date:  1972-04-13       Impact factor: 91.245

5.  Acquired angioedema associated with rectal carcinoma and its response to danazol therapy. Acquired angioedema treated with danazol.

Authors:  S H Cohen; S M Koethe; F Kozin; G Rodey; J A Arkins; J N Fink
Journal:  J Allergy Clin Immunol       Date:  1978-10       Impact factor: 10.793

6.  Methyltestosterone therapy in hereditary angioedema.

Authors:  A L Sheffer; D T Fearon; K F Austen
Journal:  Ann Intern Med       Date:  1977-03       Impact factor: 25.391

7.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities.

Authors:  J A Gelfand; R J Sherins; D W Alling; M M Frank
Journal:  N Engl J Med       Date:  1976-12-23       Impact factor: 91.245

8.  The conversion of C'IS to C'1 esterase by plasmin and trypsin.

Authors:  O D Ratnoff; G B Naff
Journal:  J Exp Med       Date:  1967-02-01       Impact factor: 14.307

9.  The inactivation of complement and its components by plasmin.

Authors:  L PILLEMER; O D RATNOFF; L BLUM; I H LEPOW
Journal:  J Exp Med       Date:  1953-04       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.